相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardioprotective mechanism of omega-3 polyunsaturated fatty acids
Jin Endo et al.
JOURNAL OF CARDIOLOGY (2016)
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
Nathan O. Stitziel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease
Frederick F. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Triglyceride-Rich Lipoproteins and Coronary Artery Disease Risk New Insights From Human Genetics
Sumeet A. Khetarpal et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis
Kenneth M. Borow et al.
ATHEROSCLEROSIS (2015)
Proof That Lower Is Better - LDL Cholesterol and IMPROVE-IT
John A. Jarcho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Triglycerides on the rise: should we swap seats on the seesaw?
Peter Libby
EUROPEAN HEART JOURNAL (2015)
A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States
Alison C. Kleiner et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2015)
Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA
Benjamin B. Albert et al.
SCIENTIFIC REPORTS (2015)
Oxidation levels of North American over-the-counter n-3 (omega-3) supplements and the influence of supplement formulation and delivery form on evaluating oxidative safety
Stefan A. Jackowski et al.
JOURNAL OF NUTRITIONAL SCIENCE (2015)
Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma
Ryo Nishio et al.
ATHEROSCLEROSIS (2014)
Residual macrovascular risk in 2013: what have we learned?
Jean-Charles Fruchart et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Eicosapentaenoic Acid Combined with Optimal Statin Therapy Improves Endothelial Dysfunction in Patients with Coronary Artery Disease
Kentaro Toyama et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
Combination Eicosapentaenoic Acid and Statin Treatment Reversed Endothelial Dysfunction in HUVECs Exposed to Oxidized LDL
R. Preston Mason et al.
Journal of Clinical Lipidology (2014)
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa for Lowering Very high triglyceridEs (EVOLVE) trial
John J. P. Kastelein et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia - Full report
Scott M. Grundy et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hazards of Hindsight - Monitoring the Safety of Nutritional Supplements
Pieter A. Cohen
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)
Kevin C. Maki et al.
CLINICAL THERAPEUTICS (2013)
Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: The omega-3 fatty acids randomized double-blind (ORD) study
Ichiro Tatsuno et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2013)
Quality analysis of commercial fish oil preparations
Jenna C. Sullivan Ritter et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2013)
n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
Maria Carla Roncaglioni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Distinct regulation of plasma LDL cholesterol by eicosapentaenoic acid and docosahexaenoic acid in high fat diet-fed hamsters: Participation of cholesterol ester transfer protein and LDL receptor
Takayuki Ishida et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2013)
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study
Elliot Offman et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2013)
Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
Christie M. Ballantyne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis
An Pan et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Dietary sources of omega 3 fatty acids: public health risks and benefits
J. A. Tur et al.
BRITISH JOURNAL OF NUTRITION (2012)
Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia
Noriko Satoh-Asahara et al.
DIABETES CARE (2012)
Administration of highly purified eicosapentaenoic acid to statin-treated diabetic patients further improves vascular function
Junko Sasaki et al.
ENDOCRINE JOURNAL (2012)
Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other Lipids: A review
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Omega-3 fatty acid supplementation and cardiovascular disease
Donald B. Jump et al.
JOURNAL OF LIPID RESEARCH (2012)
A Meta-Analysis Shows That Docosahexaenoic Acid from Algal Oil Reduces Serum Triglycerides and Increases HDL-Cholesterol and LDL-Cholesterol in Persons without Coronary Heart Disease
Adam M. Bernstein et al.
JOURNAL OF NUTRITION (2012)
Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men
Kevin Dawson et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion
S. Marlene Grenon et al.
JOURNAL OF SURGICAL RESEARCH (2012)
THE IMPACT OF A PURE-EPA OMEGA-3 FATTY ACID ON CORONARY PLAQUE STABILIZATION; A PLAQUE COMPONENT ANALYSIS WITH 64-SLICE MULTI-DETECTOR ROW COMPUTED TOMOGRAPHY
Yoshiaki Shintani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Jackie Bosch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
Melissa Y. Wei et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Long Chain Omega-3 Dietary Supplements: A Review of the National Library of Medicine Herbal Supplement Database
Atanaz Zargar et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2011)
Determination of lipid oxidation products in vegetable oils and marine omega-3 supplements
Bente Lise Halvorsen et al.
FOOD & NUTRITION RESEARCH (2011)
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability
Abbie L. Cawood et al.
ATHEROSCLEROSIS (2010)
Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents
Frida Dangardt et al.
ATHEROSCLEROSIS (2010)
Fish Oil for the Treatment of Cardiovascular Disease
Daniel Weitz et al.
CARDIOLOGY IN REVIEW (2010)
OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
Bernhard Rauch et al.
CIRCULATION (2010)
Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids
Yuriko Adkins et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
Effects of Polyunsaturated Omega-3 Fatty Acids on Responsiveness to Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention The OMEGA-PCI (OMEGA-3 Fatty Acids After PCI to Modify Responsiveness to Dual Antiplatelet Therapy) Study
Grzegorz Gajos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Daan Kromhout et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
Roland Klingenberg et al.
EUROPEAN HEART JOURNAL (2009)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
Michael H. Davidson et al.
CLINICAL THERAPEUTICS (2007)
Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes
Tomoya Mita et al.
ATHEROSCLEROSIS (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Omega-3 fatty acids and total polychlorinated biphenyls in 26 dietary supplements
SM Shim et al.
JOURNAL OF FOOD SCIENCE (2003)
Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial
F Thies et al.
LANCET (2003)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
分享论文
